• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ACW

ACTINOGEN MEDICAL LIMITED - Announcements

3.57% ! 2.9¢
Market Cap $88.91M  !

Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel... Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel therapy for neurological diseases associated with dysregulated brain cortisol. There is a strong association between cortisol and detrimental changes in the brain, affecting cognitive function, harm to brain cells and long term cognitive health.More

Recently Updated

Corporate Spotlight

Actinogen is a neurotherapeutics developer realizing a revolutionary therapy so neurology patients and their families can live their best lives.
View the full Corporate Spotlight arrow Created with Sketch.

Actinogen reaches 100th participant milestone

Announcements



ACW Program Expansion & Capital RaisingPRICE SENSITIVE25/11/21 download Created with Sketch. 271.26KB
ACW Trading HaltPRICE SENSITIVE23/11/21 download Created with Sketch. 343.76KB
ACW Appendix 3Y - Mr Malcolm McComas18/11/21 download Created with Sketch. 192.56KB
ACW Appendix 3Y - Dr George Morstyn18/11/21 download Created with Sketch. 192.58KB
ACW Appendix 3Y - Dr Geoff Brooke18/11/21 download Created with Sketch. 192.43KB
ACW Application for quotation of securities - ACW18/11/21 download Created with Sketch. 26.96KB
ACW Results of Annual General Meeting10/11/21 download Created with Sketch. 225.38KB
ACW AGM Presentations10/11/21 download Created with Sketch. 6.63MB
ACW ACW announces open IND for Phase 2 Fragile X trial & LOIPRICE SENSITIVE09/11/21 download Created with Sketch. 236.09KB
ACW Quarterly Activity Report & Appendix 4CPRICE SENSITIVE20/10/21 download Created with Sketch. 409.13KB
ACW R&D Tax Incentive Rebate received of A$1.435 millionPRICE SENSITIVE13/10/21 download Created with Sketch. 198.91KB
ACW Annual Report to Shareholders08/10/21 download Created with Sketch. 4.96MB
ACW Letter to Shareholders & Notice of Annual General Meeting08/10/21 download Created with Sketch. 776.33KB
ACW Date of AGM and Closing Date for Director Nominations22/09/21 download Created with Sketch. 158.79KB
ACW Application for quotation of securities - ACW16/09/21 download Created with Sketch. 29.79KB
ACW Appendix 4G30/08/21 download Created with Sketch. 153.69KB
ACW Actinogen Medical FY21 Results- Progressing the PipelinePRICE SENSITIVE30/08/21 download Created with Sketch. 233.75KB
ACW Appendix 4E & Annual ReportPRICE SENSITIVE30/08/21 download Created with Sketch. 2.74MB
ACW Actinogen completes global patent family grantPRICE SENSITIVE23/08/21 download Created with Sketch. 194.63KB
ACW Actinogen to present at ShareCafe Small Cap Webinar04/08/21 download Created with Sketch. 2.5MB
ACW Quarterly Activity Report & Appendix 4CPRICE SENSITIVE22/07/21 download Created with Sketch. 284.43KB
ACW First Patient Enrolled in XanaMIA trialPRICE SENSITIVE15/07/21 download Created with Sketch. 187.34KB
ACW Actinogen receives positive Pre-IND FDA advice for FXSPRICE SENSITIVE23/06/21 download Created with Sketch. 174.43KB
ACW Clinical progress for XanaMIA trialPRICE SENSITIVE21/06/21 download Created with Sketch. 137.28KB
ACW Actinogen Ethics Committee approval for XanaMIA studyPRICE SENSITIVE02/06/21 download Created with Sketch. 162.47KB
ACW Change of Share Register Notification28/05/21 download Created with Sketch. 180.68KB
ACW Response to ASX Price QueryPRICE SENSITIVE24/05/21 download Created with Sketch. 291.5KB
ACW Lapse of Unlisted Options10/05/21 download Created with Sketch. 156.33KB
ACW Strategic Update Teleconference Transcript30/04/21 download Created with Sketch. 208.67KB
ACW Strategic Update & Teleconference Call NotificationPRICE SENSITIVE21/04/21 download Created with Sketch. 3.02MB
ACW Quarterly Activity Report & Appendix 4CPRICE SENSITIVE21/04/21 download Created with Sketch. 285.3KB
ACW Appendix 3Y - Dr George Morstyn29/03/21 download Created with Sketch. 26.1KB
ACW Initial Director's Interest Notice24/03/21 download Created with Sketch. 174.49KB
ACW Actinogen CEO assumes Managing Director positionPRICE SENSITIVE24/03/21 download Created with Sketch. 159.22KB
ACW Appendix 2A15/03/21 download Created with Sketch. 192.86KB
ACW Actinogen appoints Dr Steven Gourlay as CEOPRICE SENSITIVE15/03/21 download Created with Sketch. 216.74KB
ACW Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE24/02/21 download Created with Sketch. 453.53KB
ACW Change in substantial holding12/02/21 download Created with Sketch. 94.13KB
ACW Cleansing Notice10/02/21 download Created with Sketch. 378.39KB
ACW Appendix 2A10/02/21 download Created with Sketch. 165.75KB
ACW ACW raises an addtional $3.55m under a Shortfall PlacementPRICE SENSITIVE10/02/21 download Created with Sketch. 162.1KB
ACW Final Director's Interest Notice08/02/21 download Created with Sketch. 27.77KB
ACW Resignation of Dr Bill Ketelbey as Chief Executive OfficerPRICE SENSITIVE08/02/21 download Created with Sketch. 158.41KB
ACW Expiry of Unlisted Options08/02/21 download Created with Sketch. 162.56KB
ACW FDA Grants ACW Rare Paediatric Disease Designation in FXSPRICE SENSITIVE05/02/21 download Created with Sketch. 208.32KB
ACW Pause in TradingPRICE SENSITIVE05/02/21 download Created with Sketch. 115.67KB
ACW Quarterly Activity Report & Appendix 4CPRICE SENSITIVE29/01/21 download Created with Sketch. 244.82KB
ACW Review of 2020 and outlook17/12/20 download Created with Sketch. 177.2KB
ACW Replacement Constitution27/11/20 download Created with Sketch. 323.28KB
ACW Results of Annual General Meeting27/11/20 download Created with Sketch. 223.87KB
ACW AGM Presentations27/11/20 download Created with Sketch. 1.52MB
ACW Appendix 3Y x 417/11/20 download Created with Sketch. 83KB
ACW Appendix 2A17/11/20 download Created with Sketch. 161.27KB
ACW Completion of Entitlement OfferPRICE SENSITIVE13/11/20 download Created with Sketch. 198.25KB
ACW Actinogen files new patent applicationsPRICE SENSITIVE09/11/20 download Created with Sketch. 199.08KB
ACW Retail Entitlement Offer-Closing Date Reminder05/11/20 download Created with Sketch. 162.48KB
ACW FDA IND UpdatePRICE SENSITIVE04/11/20 download Created with Sketch. 161.63KB
ACW ACW to initiate XanaFX clinical trial in Fragile X syndromePRICE SENSITIVE02/11/20 download Created with Sketch. 1.16MB
ACW Update to Appendix 3B30/10/20 download Created with Sketch. 484.63KB
ACW Quarterly Activity Report & Appendix 4CPRICE SENSITIVE29/10/20 download Created with Sketch. 328.98KB
ACW R&D Tax Incentive Rebate received of A$2.9 millionPRICE SENSITIVE27/10/20 download Created with Sketch. 191.49KB
ACW Annual Report to Shareholders26/10/20 download Created with Sketch. 1.05MB
ACW Letter to Shareholders, Notice of AGM & Proxy Form26/10/20 download Created with Sketch. 1.8MB
ACW Incorrect BPAY Biller Code provided by share registry26/10/20 download Created with Sketch. 162KB
ACW Change in substantial holding26/10/20 download Created with Sketch. 100.31KB
ACW Correction of Entitlement Offer allotment date23/10/20 download Created with Sketch. 159.47KB
ACW Letter to Ineligible Shareholders23/10/20 download Created with Sketch. 240.93KB
ACW Offer BookletPRICE SENSITIVE23/10/20 download Created with Sketch. 765.31KB
ACW Cleansing Notice22/10/20 download Created with Sketch. 267.96KB
ACW Appendix 2A22/10/20 download Created with Sketch. 167.93KB
ACW Change to Date of Annual General Meeting16/10/20 download Created with Sketch. 160.39KB
ACW Letter to Optionholders re Non-Renounceable Rights Issue15/10/20 download Created with Sketch. 364.08KB
ACW Notice under Section 708AA of the Corporations Act 2001 (Cth15/10/20 download Created with Sketch. 250.57KB
ACW Actinogen Presentation & Planned Conference CallPRICE SENSITIVE15/10/20 download Created with Sketch. 2.73MB
ACW Proposed issue of Securities - ACWPRICE SENSITIVE15/10/20 download Created with Sketch. 36.63KB
ACW ACW announces two clinical trials & launches capital raisingPRICE SENSITIVE15/10/20 download Created with Sketch. 219.11KB
ACW Trading HaltPRICE SENSITIVE13/10/20 download Created with Sketch. 131.2KB
ACW Appendix 3G02/10/20 download Created with Sketch. 227.34KB
ACW Date of AGM & Closing Date for Director Nominations29/09/20 download Created with Sketch. 161.21KB
ACW Actinogen Appoints Chief Financial Officer28/09/20 download Created with Sketch. 191.76KB
ACW Actinogen Medical Investor Presentation09/09/20 download Created with Sketch. 1.33MB
ACW Appendix 4G26/08/20 download Created with Sketch. 198.16KB
ACW Appendix 4E & Annual ReportPRICE SENSITIVE26/08/20 download Created with Sketch. 1.05MB
ACW Quarterly Activity Report & Appendix 4CPRICE SENSITIVE29/07/20 download Created with Sketch. 331.08KB
ACW Response to ASX Price QueryPRICE SENSITIVE01/07/20 download Created with Sketch. 254.37KB
ACW Market Update and ACW to Participate in BIO Digital04/06/20 download Created with Sketch. 207.6KB
ACW Actinogen Presentation at AAT-ADPD International Congress29/04/20 download Created with Sketch. 161.59KB
ACW Quarterly Activity Report & Appendix 4CPRICE SENSITIVE23/04/20 download Created with Sketch. 228.75KB
ACW Actinogen presents latest Xanamem data at AD Conference01/04/20 download Created with Sketch. 233.48KB
ACW Market Update COVID-19PRICE SENSITIVE26/03/20 download Created with Sketch. 159.31KB
ACW Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE20/02/20 download Created with Sketch. 789.69KB
ACW Additional R&D Tax Incentive rebate received17/02/20 download Created with Sketch. 154.36KB
ACW Appendix 3Y-Dr Bill Ketelbey31/01/20 download Created with Sketch. 26.99KB
ACW ASIC Form 48431/01/20 download Created with Sketch. 123.27KB
ACW Final share buy-back notice - Appendix 3F31/01/20 download Created with Sketch. 282.79KB
ACW December 2019 Quarterly UpdatePRICE SENSITIVE28/01/20 download Created with Sketch. 368.91KB
ACW Actinogen at SACHS Forum and JP Morgan week08/01/20 download Created with Sketch. 2.31MB
ACW Review of 2019 and outlook18/12/19 download Created with Sketch. 167.14KB
ACW Share Cancellation - Employee Share Plan13/12/19 download Created with Sketch. 340.7KB
ACW Managing Director share loan repayment27/11/19 download Created with Sketch. 182.95KB
ACW Program Expansion & Capital Raising
25/11/21PRICE SENSITIVE download Created with Sketch. 271.26KB
ACW Trading Halt
23/11/21PRICE SENSITIVE download Created with Sketch. 343.76KB
ACW Appendix 3Y - Mr Malcolm McComas
18/11/21 download Created with Sketch. 192.56KB
ACW Appendix 3Y - Dr George Morstyn
18/11/21 download Created with Sketch. 192.58KB
ACW Appendix 3Y - Dr Geoff Brooke
18/11/21 download Created with Sketch. 192.43KB
ACW Application for quotation of securities - ACW
18/11/21 download Created with Sketch. 26.96KB
ACW Results of Annual General Meeting
10/11/21 download Created with Sketch. 225.38KB
ACW AGM Presentations
10/11/21 download Created with Sketch. 6.63MB
ACW ACW announces open IND for Phase 2 Fragile X trial & LOI
09/11/21PRICE SENSITIVE download Created with Sketch. 236.09KB
ACW Quarterly Activity Report & Appendix 4C
20/10/21PRICE SENSITIVE download Created with Sketch. 409.13KB
ACW R&D Tax Incentive Rebate received of A$1.435 million
13/10/21PRICE SENSITIVE download Created with Sketch. 198.91KB
ACW Annual Report to Shareholders
08/10/21 download Created with Sketch. 4.96MB
ACW Letter to Shareholders & Notice of Annual General Meeting
08/10/21 download Created with Sketch. 776.33KB
ACW Date of AGM and Closing Date for Director Nominations
22/09/21 download Created with Sketch. 158.79KB
ACW Application for quotation of securities - ACW
16/09/21 download Created with Sketch. 29.79KB
ACW Appendix 4G
30/08/21 download Created with Sketch. 153.69KB
ACW Actinogen Medical FY21 Results- Progressing the Pipeline
30/08/21PRICE SENSITIVE download Created with Sketch. 233.75KB
ACW Appendix 4E & Annual Report
30/08/21PRICE SENSITIVE download Created with Sketch. 2.74MB
ACW Actinogen completes global patent family grant
23/08/21PRICE SENSITIVE download Created with Sketch. 194.63KB
ACW Actinogen to present at ShareCafe Small Cap Webinar
04/08/21 download Created with Sketch. 2.5MB
ACW Quarterly Activity Report & Appendix 4C
22/07/21PRICE SENSITIVE download Created with Sketch. 284.43KB
ACW First Patient Enrolled in XanaMIA trial
15/07/21PRICE SENSITIVE download Created with Sketch. 187.34KB
ACW Actinogen receives positive Pre-IND FDA advice for FXS
23/06/21PRICE SENSITIVE download Created with Sketch. 174.43KB
ACW Clinical progress for XanaMIA trial
21/06/21PRICE SENSITIVE download Created with Sketch. 137.28KB
ACW Actinogen Ethics Committee approval for XanaMIA study
02/06/21PRICE SENSITIVE download Created with Sketch. 162.47KB
ACW Change of Share Register Notification
28/05/21 download Created with Sketch. 180.68KB
ACW Response to ASX Price Query
24/05/21PRICE SENSITIVE download Created with Sketch. 291.5KB
ACW Lapse of Unlisted Options
10/05/21 download Created with Sketch. 156.33KB
ACW Strategic Update Teleconference Transcript
30/04/21 download Created with Sketch. 208.67KB
ACW Strategic Update & Teleconference Call Notification
21/04/21PRICE SENSITIVE download Created with Sketch. 3.02MB
ACW Quarterly Activity Report & Appendix 4C
21/04/21PRICE SENSITIVE download Created with Sketch. 285.3KB
ACW Appendix 3Y - Dr George Morstyn
29/03/21 download Created with Sketch. 26.1KB
ACW Initial Director's Interest Notice
24/03/21 download Created with Sketch. 174.49KB
ACW Actinogen CEO assumes Managing Director position
24/03/21PRICE SENSITIVE download Created with Sketch. 159.22KB
ACW Appendix 2A
15/03/21 download Created with Sketch. 192.86KB
ACW Actinogen appoints Dr Steven Gourlay as CEO
15/03/21PRICE SENSITIVE download Created with Sketch. 216.74KB
ACW Appendix 4D & Half-Year Financial Statements
24/02/21PRICE SENSITIVE download Created with Sketch. 453.53KB
ACW Change in substantial holding
12/02/21 download Created with Sketch. 94.13KB
ACW Cleansing Notice
10/02/21 download Created with Sketch. 378.39KB
ACW Appendix 2A
10/02/21 download Created with Sketch. 165.75KB
ACW ACW raises an addtional $3.55m under a Shortfall Placement
10/02/21PRICE SENSITIVE download Created with Sketch. 162.1KB
ACW Final Director's Interest Notice
08/02/21 download Created with Sketch. 27.77KB
ACW Resignation of Dr Bill Ketelbey as Chief Executive Officer
08/02/21PRICE SENSITIVE download Created with Sketch. 158.41KB
ACW Expiry of Unlisted Options
08/02/21 download Created with Sketch. 162.56KB
ACW FDA Grants ACW Rare Paediatric Disease Designation in FXS
05/02/21PRICE SENSITIVE download Created with Sketch. 208.32KB
ACW Pause in Trading
05/02/21PRICE SENSITIVE download Created with Sketch. 115.67KB
ACW Quarterly Activity Report & Appendix 4C
29/01/21PRICE SENSITIVE download Created with Sketch. 244.82KB
ACW Review of 2020 and outlook
17/12/20 download Created with Sketch. 177.2KB
ACW Replacement Constitution
27/11/20 download Created with Sketch. 323.28KB
ACW Results of Annual General Meeting
27/11/20 download Created with Sketch. 223.87KB
ACW AGM Presentations
27/11/20 download Created with Sketch. 1.52MB
ACW Appendix 3Y x 4
17/11/20 download Created with Sketch. 83KB
ACW Appendix 2A
17/11/20 download Created with Sketch. 161.27KB
ACW Completion of Entitlement Offer
13/11/20PRICE SENSITIVE download Created with Sketch. 198.25KB
ACW Actinogen files new patent applications
09/11/20PRICE SENSITIVE download Created with Sketch. 199.08KB
ACW Retail Entitlement Offer-Closing Date Reminder
05/11/20 download Created with Sketch. 162.48KB
ACW FDA IND Update
04/11/20PRICE SENSITIVE download Created with Sketch. 161.63KB
ACW ACW to initiate XanaFX clinical trial in Fragile X syndrome
02/11/20PRICE SENSITIVE download Created with Sketch. 1.16MB
ACW Update to Appendix 3B
30/10/20 download Created with Sketch. 484.63KB
ACW Quarterly Activity Report & Appendix 4C
29/10/20PRICE SENSITIVE download Created with Sketch. 328.98KB
ACW R&D Tax Incentive Rebate received of A$2.9 million
27/10/20PRICE SENSITIVE download Created with Sketch. 191.49KB
ACW Annual Report to Shareholders
26/10/20 download Created with Sketch. 1.05MB
ACW Letter to Shareholders, Notice of AGM & Proxy Form
26/10/20 download Created with Sketch. 1.8MB
ACW Incorrect BPAY Biller Code provided by share registry
26/10/20 download Created with Sketch. 162KB
ACW Change in substantial holding
26/10/20 download Created with Sketch. 100.31KB
ACW Correction of Entitlement Offer allotment date
23/10/20 download Created with Sketch. 159.47KB
ACW Letter to Ineligible Shareholders
23/10/20 download Created with Sketch. 240.93KB
ACW Offer Booklet
23/10/20PRICE SENSITIVE download Created with Sketch. 765.31KB
ACW Cleansing Notice
22/10/20 download Created with Sketch. 267.96KB
ACW Appendix 2A
22/10/20 download Created with Sketch. 167.93KB
ACW Change to Date of Annual General Meeting
16/10/20 download Created with Sketch. 160.39KB
ACW Letter to Optionholders re Non-Renounceable Rights Issue
15/10/20 download Created with Sketch. 364.08KB
ACW Notice under Section 708AA of the Corporations Act 2001 (Cth
15/10/20 download Created with Sketch. 250.57KB
ACW Actinogen Presentation & Planned Conference Call
15/10/20PRICE SENSITIVE download Created with Sketch. 2.73MB
ACW Proposed issue of Securities - ACW
15/10/20PRICE SENSITIVE download Created with Sketch. 36.63KB
ACW ACW announces two clinical trials & launches capital raising
15/10/20PRICE SENSITIVE download Created with Sketch. 219.11KB
ACW Trading Halt
13/10/20PRICE SENSITIVE download Created with Sketch. 131.2KB
ACW Appendix 3G
02/10/20 download Created with Sketch. 227.34KB
ACW Date of AGM & Closing Date for Director Nominations
29/09/20 download Created with Sketch. 161.21KB
ACW Actinogen Appoints Chief Financial Officer
28/09/20 download Created with Sketch. 191.76KB
ACW Actinogen Medical Investor Presentation
09/09/20 download Created with Sketch. 1.33MB
ACW Appendix 4G
26/08/20 download Created with Sketch. 198.16KB
ACW Appendix 4E & Annual Report
26/08/20PRICE SENSITIVE download Created with Sketch. 1.05MB
ACW Quarterly Activity Report & Appendix 4C
29/07/20PRICE SENSITIVE download Created with Sketch. 331.08KB
ACW Response to ASX Price Query
01/07/20PRICE SENSITIVE download Created with Sketch. 254.37KB
ACW Market Update and ACW to Participate in BIO Digital
04/06/20 download Created with Sketch. 207.6KB
ACW Actinogen Presentation at AAT-ADPD International Congress
29/04/20 download Created with Sketch. 161.59KB
ACW Quarterly Activity Report & Appendix 4C
23/04/20PRICE SENSITIVE download Created with Sketch. 228.75KB
ACW Actinogen presents latest Xanamem data at AD Conference
01/04/20 download Created with Sketch. 233.48KB
ACW Market Update COVID-19
26/03/20PRICE SENSITIVE download Created with Sketch. 159.31KB
ACW Appendix 4D & Half-Year Financial Statements
20/02/20PRICE SENSITIVE download Created with Sketch. 789.69KB
ACW Additional R&D Tax Incentive rebate received
17/02/20 download Created with Sketch. 154.36KB
ACW Appendix 3Y-Dr Bill Ketelbey
31/01/20 download Created with Sketch. 26.99KB
ACW ASIC Form 484
31/01/20 download Created with Sketch. 123.27KB
ACW Final share buy-back notice - Appendix 3F
31/01/20 download Created with Sketch. 282.79KB
ACW December 2019 Quarterly Update
28/01/20PRICE SENSITIVE download Created with Sketch. 368.91KB
ACW Actinogen at SACHS Forum and JP Morgan week
08/01/20 download Created with Sketch. 2.31MB
ACW Review of 2019 and outlook
18/12/19 download Created with Sketch. 167.14KB
ACW Share Cancellation - Employee Share Plan
13/12/19 download Created with Sketch. 340.7KB
ACW Managing Director share loan repayment
27/11/19 download Created with Sketch. 182.95KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
2.9¢
Change
0.001(3.57%)
Mkt cap ! $88.91M
Open High Low Value Volume
2.9¢ 2.9¢ 2.9¢ $8 276

Buyers (Bids)

No. Vol. Price($)
4 2131428 2.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.9¢ 1331801 6
View Market Depth
Last trade - 09.59am 12/09/2025 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.